Correlation Between Pharvaris and Enliven Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharvaris and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and Enliven Therapeutics, you can compare the effects of market volatilities on Pharvaris and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Enliven Therapeutics.

Diversification Opportunities for Pharvaris and Enliven Therapeutics

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Pharvaris and Enliven is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Pharvaris i.e., Pharvaris and Enliven Therapeutics go up and down completely randomly.

Pair Corralation between Pharvaris and Enliven Therapeutics

Given the investment horizon of 90 days Pharvaris BV is expected to generate 1.38 times more return on investment than Enliven Therapeutics. However, Pharvaris is 1.38 times more volatile than Enliven Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Enliven Therapeutics is currently generating about 0.05 per unit of risk. If you would invest  1,771  in Pharvaris BV on August 31, 2024 and sell it today you would earn a total of  419.00  from holding Pharvaris BV or generate 23.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pharvaris BV  vs.  Enliven Therapeutics

 Performance 
       Timeline  
Pharvaris BV 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Pharvaris BV are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Pharvaris unveiled solid returns over the last few months and may actually be approaching a breakup point.
Enliven Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Enliven Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Enliven Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pharvaris and Enliven Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharvaris and Enliven Therapeutics

The main advantage of trading using opposite Pharvaris and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.
The idea behind Pharvaris BV and Enliven Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes